In-stent restenosis: Contributions of inflammatory responses and arterial injury to neointimal hyperplasia

被引:729
|
作者
Kornowski, R
Hong, MK
Tio, FO
Bramwell, O
Wu, HS
Leon, MB
机构
[1] Washington Hosp Ctr, Dept Internal Med, Div Cardiol, Washington, DC 20010 USA
[2] Washington Hosp Ctr, Medlant Res Inst, Washington, DC 20010 USA
[3] Univ Texas, Hlth Sci Ctr, Dept Pathol, San Antonio, TX 78284 USA
关键词
D O I
10.1016/S0735-1097(97)00450-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. We examined the relative contributions of inflammation and arterial injury to neointimal formation in a porcine coronary overstretch restenosis model. Background. Previous studies established that stents cause neointimal proliferation proportional to injury, Although inflammation has been postulated to be a major contributor to restenosis after angioplasty, there is a paucity of data on the relation between inflammation and subsequent neointimal formation. Methods. Twenty-one pigs underwent balloon injury followed by implantation of oversized, tubular, slotted stents (stent/artery ratio 1.2:1) in the left anterior descending coronary artery, Morphometric analysis of the extent of injury (graded as injury score 0 to 3) and inflammation (graded as inflammation score 0 to 3) 1 month later was assessed and correlated with neointimal formation. Results. An inflammatory reaction was observed in 20 of 21 pigs, and significant positive correlations were found between the degree of arterial injury and the extent of the inflammatory reaction (r = 0.80, p < 0.01) and between the extent of inflammatory reaction and the neointimal thickness (r = 0.75, p < 0.01), neointimal area (r = 0.53, p = 0.01) and percent area stenosis (r = 0.66, p < 0.01) within the stents, Importantly, there were areas with inflammation only in the absence of injury, and vice versa, that were also associated with neointimal hyperplasia. Conclusions. These data suggest that the inflammatory reaction plays an equally important role as arterial injury in neointimal formation after coronary stenting, and that, anti-inflammatory approaches may be of value to reduce in-stent restenosis. (C) 1998 by the American College of Cardiology.
引用
收藏
页码:224 / 230
页数:7
相关论文
共 50 条
  • [31] Efficacy of helixcision for debulking neointimal hyperplasia for in-stent restenosis: A serial baseline analysis from the helixcision endoluminal in-stent excision (HELIX I) international feasibility trial.
    Nakamura, M
    Carter, AJ
    Honda, Y
    Abizaid, A
    Tofte, A
    Grube, E
    Yock, PG
    Yeung, AC
    Fitzgerald, PJ
    AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (5A): : 51G - 51G
  • [32] MECHANISM OF CORONARY IN-STENT RESTENOSIS - NEOINTIMAL PROLIFERATION OR STENT COMPRESSION - SERIAL ASSESSMENT BY INTRAVASCULAR ULTRASOUND
    KLAUSS, V
    BLASINI, R
    REGAR, E
    RIEBER, J
    KONIG, A
    MUDRA, H
    CIRCULATION, 1993, 88 (04) : 598 - 598
  • [33] Sustained attenuation of neointimal coverage over the stent following brachytherapy for in-stent restenosis - Angioscopic findings
    Awata, Masaki
    Kotani, Jun-ichi
    Nanto, Shinsuke
    Uematsu, Masaaki
    Morozumi, Takakazu
    Hori, Masatsugu
    Nagata, Seiki
    CIRCULATION JOURNAL, 2006, 70 (07) : 846 - 850
  • [34] CORONARY RESTENOSIS - DEVELOPMENT OF NEOINTIMAL HYPERPLASIA IN EXPERIMENTAL VASCULAR INJURY
    SRIVATSA, SS
    EDWARDS, WD
    SIMARI, RD
    HOLMES, DR
    SCHWARTZ, RS
    JOURNAL OF INVASIVE CARDIOLOGY, 1993, 5 (09): : 334 - 344
  • [35] Validation of the in vivo intravascular ultrasound measurement of in-stent neointimal hyperplasia volumes
    Mehran, R
    Mintz, GS
    Hong, MK
    Tio, FO
    Bramwell, O
    Brahimi, A
    Kent, KM
    Pichard, AD
    Satler, LF
    Popma, JJ
    Leon, MB
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (03) : 794 - 799
  • [36] Association between periprocedural myocardial injury and neointimal characteristics in patients with in-stent restenosis: an optical coherence tomography study
    Shen, Youcheng
    Wang, Xi
    Gu, Ning
    Liu, Zhijiang
    Rong, Jidong
    Shen, Changyin
    Zhang, Wei
    Chen, Panke
    Deng, Yi
    Deng, Chancui
    Ma, Shuai
    Zhao, Yongchao
    Zhao, Ranzun
    Shi, Bei
    CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2024, 14 (01) : 5 - 17
  • [37] The dose-effect of intracoronary β-brachytherapy on in-stent neointimal hyperplasia inhibition
    Carlier, SG
    Fox, T
    Hassan, AHM
    Kozuma, K
    Costa, MA
    Lee, DP
    Okura, H
    Coen, VL
    Levendag, PC
    Hoed, DD
    Fitzgerald, PJ
    Serruys, PW
    CIRCULATION, 2000, 102 (18) : 569 - 570
  • [38] Predictors of neointimal regression six months after intravascular brachytherapy for in-stent restenosis
    Okura, H
    Limpijankit, T
    Kaneda, H
    Sakurai, R
    Mintz, GS
    Lansky, AJ
    Waksman, R
    Yock, PG
    Honda, Y
    Fitzgerald, PJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 9A - 9A
  • [39] Saline infusion via local drug delivery catheters is associated with increased neointimal hyperplasia in a porcine coronary in-stent restenosis model
    Kim, WH
    Hong, MK
    Kornowski, R
    Tio, FO
    Wu, H
    Seabron, R
    Pierre, T
    Collins, S
    Leon, MB
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) : 278A - 278A
  • [40] A proliferation analysis of arterial neointimal hyperplasia: Lessons for antiproliferative restenosis therapies
    Schwartz, RS
    Chu, A
    Edwards, WD
    Srivatsa, SS
    Simari, RD
    Isner, JM
    Holmes, DR
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 1996, 53 (01) : 71 - 80